SCHEMBL26813630

SCHEMBL26813630

Fc1ccc(F)c(-c2ccc3c(c2)CCC3)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.41
RAB9A P51151 6/20 0.41
CYP11B1 P15538 2/20 0.41
CYP11B2 P19099 2/20 0.41
TDP2 O95551 1/20 0.41
FFAR4 Q5NUL3 2/20 0.40
NPY5R Q15761 2/20 0.39
NFKB1 P19838 2/20 0.39
NFKB2 Q00653 2/20 0.39
RELA Q04206 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
TP53 P04637 1/20 0.39
CASP3 P42574 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
PARP1 P09874 1/20 0.38
PARP10 Q53GL7 1/20 0.38
HRH3 Q9Y5N1 1/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20341751 0.83 HSD17B1 (0.44) NPC1RAB9AFFAR4NFKB1NFKB2
SCHEMBL8632736 0.80 PARP1 (0.50) NPC1RAB9ACYP11B1CYP11B2NFKB1
SCHEMBL20099201 0.79 BACE1 (0.45) NPC1RAB9ATDP2NPY5R
SCHEMBL31593929 0.78 NPC1 (0.52) NPC1RAB9ANFKB1NFKB2RELA
SCHEMBL798296 0.78 NPC1 (0.52) NPC1RAB9ANFKB1NFKB2RELA
SCHEMBL24286750 0.78 PARP10 (0.42) NPC1RAB9ATDP2NPY5RTP53
SCHEMBL8635352 0.76 PARP1 (0.50) NPC1RAB9ACYP11B1CYP11B2NFKB1
Ethane SCHEMBL28782548 0.74 NPC1 (0.49) NPC1RAB9ANFKB1NFKB2RELA
SCHEMBL5245075 0.74 NPC1 (0.47) NPC1RAB9ANFKB1NFKB2RELA
SCHEMBL30634164 0.74 NPC1 (0.47) NPC1RAB9ANFKB1NFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023225162-A1 ANTIVIRAL INDOLINYL COMPOUNDS AND USES THEREOF GILEAD SCIENCES, INC. (US) 2023-11-23 WO disclosed